Why is Epigral falling/rising?

As of 29-Jul, Epigral Ltd's stock price is rising, currently at 1,956.55, reflecting an increase of 136.55 or 7.5%. The stock has shown a positive trend today, outperforming its sector by 7.08% and reversing a two-day decline. It reached an intraday high of Rs 1971.1, indicating strong trading activity. Over the past week, the stock has gained 9.55%, while its performance over the last month shows an increase of 8.62%. The company has demonstrated high management efficiency with a return on capital employed (ROCE) of 23.84% and a low debt to EBITDA ratio of 1.46 times, which supports its ability to service debt. Additionally, Epigral has reported positive results for the last five consecutive quarters, with a significant growth in profit after tax and net sales.
In the broader market context, while the Sensex has experienced a decline of 1.03% over the past week and 3.24% over the past month, Epigral's strong performance stands out, particularly as it has generated a return of 15.77% over the past year compared to the market's negative returns. This indicates that despite a challenging market environment, Epigral has managed to maintain investor interest and confidence, contributing to its rising stock price. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 19.09% against the five-day average, which could be a point of concern moving forward.